This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Cardiovascular Disease Obesity Research 
Science Daily - Heart Disease
APRIL 8, 2025
New research has uncovered a surprising culprit underlying cardiovascular diseases in obesity and diabetes -- not the presence of certain fats, but their suppression. Ironically, the findings could ultimately lead to therapies that maintain high levels of these protective lipids in patients with obesity.
68 
Frontiers in Cardiovascular Medicine
MARCH 14, 2025
BackgroundObesity is a global epidemic and a major risk factor for cardiovascular diseases. This study aims to investigate the impact of weight loss after LSG on the left ventricular myocardial work (LVMW) in obese patients and explore the clinical value of the left ventricular pressure - strain loop (LV - PSL).MethodsThirty
52 
Medical Xpress - Cardiology
APRIL 8, 2025
New research from Weill Cornell Medicine has uncovered a surprising culprit underlying cardiovascular diseases in obesity and diabetesnot the presence of certain fats, but their suppression. The study, published Feb.
76 
Cardiovascular Diabetology
SEPTEMBER 15, 2024
Background Heart failure (HF) is a serious and common condition affecting millions of people worldwide, with obesity being a major cause of metabolic disorders such as diabetes and cardiovascular disease. During the 4.22-year
98 
Cardiovascular Diabetology
JUNE 5, 2024
Cardiovascular disease (CVD) is closely associated with the triglyceride glucose (TyG) index and its related indicators, particularly its combination with obesity indices. However, there is limited research on.
Cardiometabolic Health Congress
JANUARY 16, 2025
Atherosclerosis (ASVD) remains a leading driver of cardiovascular disease (CVD), a global health challenge that claims millions of lives each year. LDL Management: The Lower for Longer Approach Research consistently supports the mantra, Lower for Longer is Better. But what if prevention could rewrite the narrative?
Circulation
MAY 20, 2024
Obesity is a recognized public health epidemic with a prevalence that continues to increase dramatically in nearly all populations, impeding progress in reducing incidence rates of cardiovascular disease. Circulation, Ahead of Print.
78 
Cardiometabolic Health Congress
JANUARY 3, 2024
In today’s society, the prevalence of obesity has become a significant concern. have obesity, and this rate has increased by more than 10 percentage points in the past two decades. Understanding the prevalence of obesity is crucial in comprehending why events like Healthy Weight Week are essential. of adults in the U.S.
97 
Cardiovascular Diabetology
SEPTEMBER 11, 2024
Cardiovascular disease represents a significant risk factor for mortality in individuals with type 2 diabetes mellitus (T2DM). High-density lipoprotein (HDL) is believed to play a crucial role in maintaining c.
130 
Journal of the American Heart Association
FEBRUARY 14, 2024
Driven by common pathophysiologic underpinnings (eg, inflammation and neurohormonal dysregulation), cardiovascular disease, cognitive impairment, and frailty also share the following risk factors: hypertension, diabetes, obesity, sedentary behavior, and tobacco use.
DAIC
JUNE 18, 2024
A projected rise in heart disease and stroke – along with several key risk factors, including high blood pressure and obesity – is likely to triple related costs to $1.8 population could be affected by cardiovascular disease within the next 30 years, according to two new science reports. and Susan F. to 61% of the U.S.
105 
Medical Xpress - Cardiology
APRIL 2, 2024
Changes in the gut microbiome have been implicated in a range of diseases including type 2 diabetes, obesity, and inflammatory bowel disease.
104 
Cardiovascular Diabetology
JULY 10, 2024
The triglyceride-glucose (TyG) index and its combination with obesity indicators can predict cardiovascular diseases (CVD). However, there is limited research on the relationship between changes in the triglyc.
CardiacWire
MAY 8, 2024
A new JAMA study revealed that a shocking 90% of US adults are at risk of developing cardiovascular-kidney-metabolic (CKM) syndrome, underscoring the need for preventative action before we face a wave of CKM-related heart disease. Stage 4 (heart disease, with or without kidney disease) – 9.2% in Whites).
116 
Cardiovascular Diabetology
JANUARY 23, 2025
Obesity, a major risk factor for cardiovascular disease (CVD), is associated with hypertension and vascular dysfunction. Perivascular adipose tissue (PVAT), a metabolically active tissue surrounding blood vess.
52 
Cardiovascular Diabetology
MAY 28, 2024
Triglyceride and glucose (TyG) index, a surrogate marker of insulin resistance, has been validated as a predictor of cardiovascular disease. However, effects of TyG-related indices combined with obesity marker.
Cardiovascular Diabetology
JANUARY 7, 2025
Among hypertensive cohorts across different nations, the relationship between the triglyceride-glucose index (TyG) and its conjunction with obesity metrics in relation to cardiovascular disease (CVD) incidence.
52 
DAIC
MARCH 26, 2024
24 theme of Cardiovascular Care for All, we will highlight our commitment to underserved populations and present subset analyses in women and Hispanic/Latinx patients as well as in patients with obesity." "Complementing the ACC.24
105 
Dr. Paddy Barrett
DECEMBER 13, 2024
When it comes to cardiovascular disease, two of the biggest risk factors we must consider are: ApoB concentration - A measure of the number of circulating lipid particles. Trends in the number of obese and severely obese people by region. Rates of obesity have tripled in the last 60 years. But only moderately.
Medical Xpress - Cardiology
JANUARY 9, 2025
For overweight or obese individuals without diabetes, but with pre-existing cardiovascular disease, semaglutide (Ozempic, Wegovy) is not cost-effective at current pricing, new research shows. However, with price reductions or rebates up to 50%, it could meet the benchmark for value in health care.
59 
Cardiometabolic Health Congress
JUNE 7, 2024
Ballantyne, MD , emphasized that while fellows may consider prevention “boring,” it is crucial for avoiding resource-intensive late-stage cardiovascular disease (CVD). He highlighted that cardiovascular health is essential for cognitive health, noting the common occurrence of vascular dementia.
Cardiovascular Diabetology
JANUARY 2, 2024
Obesity has increased in recent years with consequences on diabetes and other comorbidities. Thus, 1 out of 3 diabetic patients suffers cardiovascular disease (CVD). The network among glucose, immune system, e.
66 
Circulation: Genomic and Precision Medicine
NOVEMBER 28, 2023
Background:Proteomic profiling could potentially disclose new pathophysiological pathways for cardiovascular diseases (CVD) and improve prediction at the individual level. Circulation: Genomic and Precision Medicine, Ahead of Print.
Frontiers in Cardiovascular Medicine
MARCH 3, 2025
IntroductionSystemic inflammation is recognised as a critical driver of atherosclerotic cardiovascular disease (ASCVD), especially in patients with comorbid chronic kidney disease (CKD).
DAIC
APRIL 6, 2024
The Minneapolis Heart Institute Foundation (MHIF) is presenting leading research focused on trends in ST-elevation myocardial infarction (STEMI), the most severe form of a heart attack, at the American College of Cardiology’s Annual Scientific Session (ACC.24), 24), being held April 6-8 in Atltanta, GA.
52 European Journal of Heart Failure
DECEMBER 13, 2023
Association between epicardial adipose tissue (EAT) and cardiac dysfunction in severe obesity. Abstract Aim Epicardial adipose tissue (EAT) plays a role in obesity-related heart failure with preserved ejection fraction. BMI, body mass index; GLS, global longitudinal strain; LASct, left atrial contractile strain. p = 0.045).
40 
Cardiovascular Diabetology
FEBRUARY 27, 2025
Cardiovascular-kidney-metabolic (CKM) syndrome has been recently proposed by American Heart Association recently. The triglyceride glucose (TyG) index and TyG-related indices combined with obesity indicators h.
52 
Cardiovascular Diabetology
SEPTEMBER 8, 2024
Visceral adipose tissue in individuals with obesity is an independent cardiovascular risk indicator. However, it remains unclear whether adipose tissue influences common cardiovascular diseases, such as athero.
Cardiometabolic Health Congress
JUNE 24, 2024
As a leader in the field of research-based cardiometabolic health education, CMHC is proud to present its CME education outcomes study at ADA (American Diabetes Association) 2024 Scientific Sessions, which offers its education-focused agenda to a wide number of healthcare practitioners from all areas of the U.S.
52 
Frontiers in Cardiovascular Medicine
MARCH 6, 2024
Cardiomyopathy, a heterogeneous pathological condition characterized by changes in cardiac structure or function, represents a significant risk factor for the prevalence and mortality of cardiovascular disease (CVD). Research conducted over the years has led to the modification of definition and classification of cardiomyopathy.
Physiologically Speaking
DECEMBER 27, 2023
The quest to determine whether plant-based diets surpass omnivorous diets in their heart healthfulness has been ongoing for decades, yielding inconclusive results despite dedicated research endeavors. Recent research underscores the critical role of gene-nutrient interactions — so-called nutrigenomics.
69 
Science Daily - Heart Disease
NOVEMBER 13, 2023
Semaglutide reduced cardiovascular events by 20% in adults with overweight or obesity and established cardiovascular disease who do not have diabetes, according to new research. of their body weight and experienced improvements in other risk factors for cardiovascular disease.
40 
Cardiometabolic Health Congress
OCTOBER 18, 2024
are critical in uncovering excessive daytime sleepiness—a known marker for cardiovascular risk. Sleep and Cardiometabolic Risk Dr. Somers delves into the growing body of research connecting poor sleep with heightened cardiometabolic risk.
DAIC
FEBRUARY 29, 2024
Five highly-anticipated late-breaking clinical trial sessions, an ACC/AHA guidelines update session and a host of featured clinical research sessions have been announced by program planners for the American College of Cardiology’s 73 rd Annual Scientific Session & Expo to be held April 6-8 in Atlanta, GA.
103 
Physiologically Speaking
DECEMBER 27, 2023
The quest to determine whether plant-based diets surpass omnivorous diets in their heart healthfulness has been ongoing for decades, yielding inconclusive results despite dedicated research endeavors. Recent research underscores the critical role of gene-nutrient interactions — so-called nutrigenomics.
52 
Cardiometabolic Health Congress
JULY 12, 2023
For instance, a pediatric provider may be only interested in topics pertaining to childhood obesity. They could find resources and education focused on that condition within both the Obesity Management and Pediatrics hubs. ” Learners can see some of the CMHC experts in person on Aug.
40 
Cardiometabolic Health Congress
SEPTEMBER 29, 2023
Cardiometabolic Health Congress faculty member, Fátima Rodriguez, MD, MPH, has committed much of her clinical and research efforts to reducing health disparities in Hispanic-American communities. Cardiometabolic conditions – specifically obesity, diabetes and heart disease – disproportionately affect the 60 million people in the U.S.
Cardiometabolic Health Congress
OCTOBER 25, 2024
Keynote speaker and atherosclerosis expert Peter Libby, MD , captivated the audience with an update on his research into inflammation and atherosclerosis. He discussed therapeutic options not only for treating atherosclerosis but also for preventing cardiovascular disease. Experts like Louis J.
64 
Journal of the American Heart Association
FEBRUARY 29, 2024
BackgroundAsian people in the United States have different sociodemographic and health‐related characteristics that might affect cardiovascular disease (CVD) risk by ethnicity and birthplace. However, they are often studied as a monolithic group in health care research. Participants' mean (±SD) age was 49±0.1
40 
Cardiometabolic Health Congress
AUGUST 14, 2024
Themed “Decoding the Constellation of Cardiometabolic Health and Risk Factors,” this year’s congress will tackle the growing health threat posed by cardiometabolic diseases, affecting 47 million people in the US. Singh, MBBS, FRCP, MBA Advances in Obesity Pharmacotherapy Louis J. Presenter: Michael D.
72 
DAIC
MAY 10, 2024
Variable LN morphology on screening mammograms in women with obesity due to ectopic fat deposition. reviewed patients (women, 40–75 years) without known coronary artery disease who had a routine screening mammogram and cardiovascular risk factors available in the EMR within 1 year of the index mammogram (January 1, 2011–December 31, 2012).
Dr. Malcolm Kendrick
AUGUST 26, 2022
26th August 2022 And so, after a great deal of faffing about, my article on cardiovascular disease ‘Assessing cardiovascular disease: looking beyond cholesterol’ has been made free to view. Eric Westman is a staunch ally in the crusade to look at different causal models of cardiovascular disease.
Circulation: Heart Failure
MARCH 8, 2024
The prevalence of HF risk factors was high: hypertension, 61.9%; former or current smoking, 53.7%; obesity 34.8%; diabetes; 24.7%; and chronic kidney disease; 22%. Overt cardiovascular disease, which ranged from 2.1% (HF) to 13.6% (atrial fibrillation), was less common. were female, 25.6% were Black, 12.8% were White.
Dr. S. Venkatesan MD
JANUARY 21, 2024
Despite the evidence suggesting a clear inverse relationship between HDL cholesterol concentration and the risk for cardiovascular disease, plasma HDL cholesterol levels do not predict the functionality and composition of HDLs. Lipids in Cardiovascular Disease Eduardo Z. HDL : The untold story ! Biomedicines. Cardiovasc.
52
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content